Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin/sulbactam + minocycline vs ampicillin/sulbactam + colistin for Acinetobacter ventilator-associated pneumonia
IRCT20150721023282N31Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventilator-associated pneumonia (VAP) comparing Ampicillin/sulbactam + minocycline with Ampicillin/sulbactam + colistin (2 arms). Started Apr 2026; status: recruiting.
02
Drugs
ampicillin + sulbactamminocyclinecolistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20150721023282N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150721023282N31.